Home › Trial NCT06427993
Urine DNA Methylation Detection for Hematuria Evaluation
- Trial IDNCT06427993
- StatusUnknown
- PhaseN/A
- Study typeObservational
- SponsorChanghai Hospital
- Enrollment71
- Start date2024-06-15
- ConditionsHematuria · Urothelial Carcinoma · Bladder Cancer · Ureter Cancer · Renal Pelvis Cancer
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.